Homburger has advised Eli Lilly. LimmaTech is supported by Moelis & Company UK LLP as financial advisor and Goodwin Procter and VISCHER as legal advisors. On...
Eli Lilly Acquires LimmaTech Biologics for Up to USD 780 Million
CDR-Life Inc’s $76 Million Series A Financing Round
Homburger advised CDR-Life in the transaction. CDR-Life Inc, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, announced the closing...


























